These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26806754)

  • 1. [Correlation of IL-8 and IL-6 in prostatic fluid with serum prostate-specific antigen level in patients with benign prostatic hyperplasia complicated by prostatitis].
    Ren X; Wu C; Yu Q; Zhu F; Liu P; Zhang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):135-9. PubMed ID: 26806754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
    Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
    Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PSA in prostatic fluid].
    Lehmann K; Simmler F; Schmucki O; Hauri D
    Urologe A; 1994 May; 33(3):232-4. PubMed ID: 7519804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
    Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
    Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of benign prostatic hyperplasia complicated by chronic prostatitis].
    Chang DG; Li GS; Zhang PH; Wu TL; Mei XF; Cao J; Gao P
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):830-3. PubMed ID: 21171270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer.
    Irani J; Millet C; Levillain P; Doré B; Begon F; Aubert J
    Eur Urol; 1996; 29(4):407-12. PubMed ID: 8791046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between TCM syndrome types and clinical symptoms of benign prostatic hyperplasia with chronic prostatitis].
    Huang XF; Ning KQ; Wang Q; Liu T; He Y; Xue JG; Dai LQ; Zhu YK
    Zhonghua Nan Ke Xue; 2017 Dec; 23(12):1111-1115. PubMed ID: 29738184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic prostatic inflammation in men with clinical BPH and erectile dysfunction affects the positive predictive value of prostate-specific antigen.
    Agnihotri S; Mittal RD; Kapoor R; Mandhani A
    Urol Oncol; 2014 Oct; 32(7):946-51. PubMed ID: 24996777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic prostatitis on angiogenic activity and serum prostate specific antigen level in benign prostatic hyperplasia.
    Koseoglu RD; Erdemir F; Parlaktas BS; Filiz NO; Uluocak N; Etikan I
    Kaohsiung J Med Sci; 2007 Aug; 23(8):387-94. PubMed ID: 17666305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
    Grigor'ev ME; Mazo EB; Chekhonin VP
    Urol Nefrol (Mosk); 1998; (4):33-7. PubMed ID: 9727319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
    Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
    Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of chronic prostatitis by noninvasive methods in elderly patients with benign prostatic hyperplasia in China.
    Cao Q; Wu Y; Guan W; Zhu Y; Qi J; Xu D
    Andrologia; 2021 Jul; 53(6):e14055. PubMed ID: 33798278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
    Zhang HT; Xu Y; Chang JW; Zhang ZH; Liu RL; Ma BJ
    Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of benign prostate hyperplasia with prostatitis].
    Long Z; He L; Zhong K; Zhang Y; Yue D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):381-5. PubMed ID: 20448364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia.
    Hasui Y; Marutsuka K; Asada Y; Ide H; Nishi S; Osada Y
    Prostate; 1994 Aug; 25(2):91-6. PubMed ID: 7518599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.